» Articles » PMID: 37728462

"The Obesity Pandemic" in the COVID-19 Pandemic - New Treatment for an Old Problem

Overview
Publisher Termedia
Specialty Pediatrics
Date 2023 Sep 20
PMID 37728462
Authors
Affiliations
Soon will be listed here.
Abstract

Obesity is a worldwide problem, and the fact that it increasingly affects children and adolescents is worrying. The COVID-19 pandemic and the restrictions introduced affected the physical activity of children and adolescents, and changed their lifestyle and the amount of time spent in front of screens, which are significant factors correlated with weight gain. Due to the scale of the problem of obesity and overweight, much attention is currently paid to seeking effective forms of therapy in these different, difficult circumstances. Interventions promoting a healthy lifestyle among obese children after the COVID-19 pandemic are particularly important and necessary. This article provides a review of the literature on the recent worsening of obesity in the paediatric population, with particular emphasis on the importance of the COVID-19 pandemic. New methods of fighting obesity with the use of telemedicine and current methods of pharmacotherapy, including new drugs, are presented.

Citing Articles

Effects of Exergaming on Morphological Variables, Biochemical Parameters, and Blood Pressure in Children and Adolescents with Overweight/Obesity: A Systematic Review with Meta-Analysis of Randomized Controlled Trials.

Hernandez-Martinez J, Perez-Carcamo J, Melki H, Cid-Calfucura I, Vasquez-Carrasco E, Delgado-Floody P Children (Basel). 2025; 12(1).

PMID: 39857860 PMC: 11763999. DOI: 10.3390/children12010029.


Obesity-Related Complications Including Dysglycemia Based on 1-h Post-Load Plasma Glucose in Children and Adolescents Screened before and after COVID-19 Pandemic.

Smyczynska J, Olejniczak A, Rozycka P, Chylinska-Fratczak A, Michalak A, Smyczynska U Nutrients. 2024; 16(15).

PMID: 39125447 PMC: 11314267. DOI: 10.3390/nu16152568.


Not Only Metabolic Complications of Childhood Obesity.

Ciezki S, Odyjewska E, Bossowski A, Glowinska-Olszewska B Nutrients. 2024; 16(4).

PMID: 38398863 PMC: 10892374. DOI: 10.3390/nu16040539.


The Ongoing Impact of COVID-19 on Pediatric Obesity.

Iacopetta D, Catalano A, Ceramella J, Pellegrino M, Marra M, Scali E Pediatr Rep. 2024; 16(1):135-150.

PMID: 38391001 PMC: 10885050. DOI: 10.3390/pediatric16010013.


The ongoing impact of obesity on childhood hypertension.

Myette R, Flynn J Pediatr Nephrol. 2024; 39(8):2337-2346.

PMID: 38189961 DOI: 10.1007/s00467-023-06263-8.

References
1.
Williams L, Padhukasahasram B, Ahmedani B, Peterson E, Wells K, Burchard E . Differing effects of metformin on glycemic control by race-ethnicity. J Clin Endocrinol Metab. 2014; 99(9):3160-8. PMC: 4154100. DOI: 10.1210/jc.2014-1539. View

2.
Stavridou A, Kapsali E, Panagouli E, Thirios A, Polychronis K, Bacopoulou F . Obesity in Children and Adolescents during COVID-19 Pandemic. Children (Basel). 2021; 8(2). PMC: 7918914. DOI: 10.3390/children8020135. View

3.
Czepiel K, Perez N, Reyes K, Sabharwal S, Stanford F . Pharmacotherapy for the Treatment of Overweight and Obesity in Children, Adolescents, and Young Adults in a Large Health System in the US. Front Endocrinol (Lausanne). 2020; 11:290. PMC: 7237714. DOI: 10.3389/fendo.2020.00290. View

4.
Sidor A, Rzymski P . Dietary Choices and Habits during COVID-19 Lockdown: Experience from Poland. Nutrients. 2020; 12(6). PMC: 7352682. DOI: 10.3390/nu12061657. View

5.
Mayer-Davis E, Dabelea D, Lawrence J . Incidence Trends of Type 1 and Type 2 Diabetes among Youths, 2002-2012. N Engl J Med. 2017; 377(3):301. PMC: 5639715. DOI: 10.1056/NEJMc1706291. View